Microbiome Composition Determines Azithromycin Effect in Asthma

Abstract

Listen

Translate article

Research Article| September 01 2021 Microbiome Composition Determines Azithromycin Effect in Asthma AAP Grand Rounds (2021) 46 (3): 29. https://doi.org/10.1542/gr.46-3-29 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Microbiome Composition Determines Azithromycin Effect in Asthma. AAP Grand Rounds September 2021; 46 (3): 29. https://doi.org/10.1542/gr.46-3-29 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All PublicationsAll JournalsAAP Grand RoundsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP NewsAll AAP Sites Search Advanced Search Topics: asthma, azithromycin, microbiome Source: Thorsen J, Stokholm J, Rasmussen MA, et al. The airway microbiota modulates effect of azithromycin treatment for episodes of recurrent asthma-like symptoms in preschool children: a randomized clinical trial. Am J Respir Crit Care Med. 2021;204(2):149-158; doi: https://doi.org/10.1164/rccm.202008-2926OCGoogle Scholar Investigators from the University of Copenhagen, Denmark, conducted a secondary analysis of data collected during a prospective study to evaluate the effects of airway microbiota on the duration of asthma-like symptoms in young children. Children who initially were enrolled in the Copenhagen Studies on Asthma in Children 2010 (COPSAC) were eligible for inclusion in the current analysis. For COPSAC, mother-child dyads were enrolled when the mother was in weeks 22-26 of pregnancy. After birth, parents recorded daily symptoms in their children on a longitudinal basis. Children were classified as having recurrent asthma-like symptoms if... You do not currently have access to this content.